FDA’s Project FrontRunner: A Path Forward for Cancer Drug Development
The FDA’s Oncology Center of Excellence (OCE) is shifting the paradigm in cancer treatment development with Project FrontRunner.
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
1 min read
JoAnn Vormschlag : Published Updated
Veristat held its first retirement party on March 31st, 2015 for our good friend and colleague, Bonnie Moores. Bonnie started with Veristat in 2007 and has been a valuable team member ever since. She was the first face we saw when we walked in the door every morning, went above and beyond her job description on more occasions than we can count, and always had a kind word to say.
To wish her a fond farewell we threw her a party full of her favorite things: good food, good friends, and Red Sox tickets!
Bonnie leaves us in the capable hands of her replacement, Stephanie Jazz. When Stephanie isn't at work, she enjoys her role as a Trivia Hostess at local restaurants.
We're excited to have you on the team, Stephanie!
The FDA’s Oncology Center of Excellence (OCE) is shifting the paradigm in cancer treatment development with Project FrontRunner.
Discover the benefits of working with a Functional Service Provider (FSP) for clinical trials. Learn about the critical factors to consider when...
Delve into the critical steps for Structure-Data (SD) File preparation for FDA regulatory submissions. Learn how Veristat can ensure your submission...